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To	 evaluate	 the	 association	 of	 alcohol	 intake	 with	 the	 risk	 of	 breast	 cancer	 in	 post-menopausal	
women,	we	analyzed	the	data	from	an	international	case-control	study	conducted	in	five	European	




were	 1.00	 (0.60-1.67),	 1.01	 (0.60-1.73),	 and	 1.18	 (0.69-2.03).	 The	 adjusted	 relative	 risk	 for	 ex-
drinkers	was	 1.73	 (1.07-2.79).	 Among	 both	 current	 drinkers	 and	 ex-drinkers,	 the	 relative	 risk	was	
higher	for	those	with	body	mass	index	above	the	median	compared	to	those	with	body	mass	index	
below	the	median.	These	results	do	not	support	a	dose-response	effect	of	alcohol	on	breast	cancer	








In	 1977,	 Williams	 and	 Horm	 [41]	 reported	 increased	 risk	 of	 cancer	 of	 the	 oral	 cavity,	 larynx,	
esophagus,	 colon,	 rectum,	 breast	 and	 thyroid	 among	 participants	 in	 the	 Third	 National	 Cancer	
Survey	who	consumed	alcohol	regularly	compared	to	those	who	did	not.	Since	that	report,	several	
case-control	 and	 follow-up	 studies	 have	 shown	 a	 small	 but	 positive	 increase	 in	 breast	 cancer	 risk	
among	 women	 who	 consume	 alcohol	 regularly,	 although	 other	 studies	 have	 failed	 to	 show	 any	
association	 [2,	 26].	 Two	 meta-analyses	 of	 alcohol	 and	 breast	 cancer	 have	 shown	 a	 weak	 but	
significant	positive	dose-response	effect	[21,	22],	although	a	third	meta-analysis	concluded	that	the	
dose-response	 effect	 is	 evident	 only	 in	 hospital-based	 case-control	 studies	 [28],	 and	 a	 pooled	
analysis	of	six	dietary	case-control	studies	suggested	that	the	association	is	limited	to	heavy	drinkers	
[17].	Epidemiological	studies	have	also	suggested	that	 the	effect	of	alcohol	may	be	stronger	when	





carcinogenic	 effect	 of	 alcohol,	 no	 definitive	 mechanism	 has	 yet	 been	 established	 [26].	 Finally,	
alcohol	 intake	has	not	been	found	to	consistenly	 induce	cancer	 in	experimental	animals	[2]	and	its	
reported	co-carcinogenic	effect	in	animal	models	of	breast	cancer	[11]	has	been	difficult	to	replicate	
consistently	[13,	24,	25].	
To	 further	 investigate	 the	 relation	between	alcohol	 intake	and	breast	 cancer	 risk	and	 the	possible	
interactions	 with	 age	 at	 onset	 of	 regular	 drinking,	 body	 mass	 index	 and	 estrogen	 replacement	
therapy,	we	have	examined	data	from	the	“EURopean	study	on	Antioxidants,	Myocardial	Infarction	






Study design and subject  recruitment 
The	methods	of	the	EURAMIC	study	have	been	described	in	detail	elsewhere	[18,	37].	Briefly,	breast	
cancer	 cases	 and	 controls	were	 recruited	 from	5	 European	 countries	 (Germany,	Northern	 Ireland,	
the	Netherlands,	Spain,	and	Switzerland).	Eligible	subjects	were	postmenopausal	women,	aged	50-
74	years,	native	residents	speaking	the	official	local	language	of	the	country	of	recruitment.	Subjects	
were	excluded	 if	 they	had	a	previous	history	of	breast	 cancer,	 a	history	of	drug	or	 alcohol	 abuse,	
major	 psychiatric	 disorders,	 if	 they	 were	 institutionalized,	 or	 if	 they	 had	 modified	 their	 dietary	








Controls	 were	 women	 without	 breast	 cancer,	 frequency-matched	 for	 age	 in	 5-year	 intervals	 and	
center.	 In	 two	 centers,	 random	 samples	 from	 local	 population	 registries	 were	 used	 (Germany,	
Switzerland).	Where	 it	was	thought	that	 low	response	rates	from	population	based	samples	would	
compromise	 internal	validity,	 control	 subjects	were	selected	via	a	 random	sample	by	 the	patient’s	
general	practitioner	(Netherlands,	Northern	Ireland,	Spain).		
Cases	and	controls	were	recruited	concurrently	during	1991	and	1992.	Response	rates	were	85.9%	
and	 41.3%	 for	 cases	 and	 controls,	 respectively.	 Informed	 consent	 was	 obtained	 from	 study	
participants	 in	 accordance	 with	 the	 ethical	 standards	 of	 the	 responsible	 committees	 on	 human	
experimentation	for	each	center.		
Data col lect ion 
Information	on	smoking	habits,	reproductive	and	medical	history	and	anthropometric	measures	was	
collected	 for	 all	 subjects	 by	 interview.	 Specific	 items	 related	 to	 the	 reproductive	 and	 hormonal	
history	 included	 age	 at	 menarche,	 age	 at	 first	 childbirth,	 parity,	 use	 of	 oral	 contraceptives	 or	
estrogen	 replacement	 therapy,	 age	 at	menopause	 and	 type	of	menopause.	 Socioeconomic	 status,	
family	 history	 of	 breast	 cancer	 and	 alcohol	 intake	 were	 assessed	 through	 locally-developed	
questionnaires.	Study	participants	were	asked	about	the	frequency	and	amount	of	alcoholic	drinks	
usually	consumed	during	work	days	and	during	the	weekend	in	the	past	year,	as	well	as	the	age	at	
starting	 regular	drinking	and	past	drinking	habit.	 To	obtain	 the	 total	 amount	of	 alcohol	 consumed	
per	week,	we	calculated	the	total	number	of	units	of	alcohol	consumed	per	week	and	assumed	that	




Stat ist ical  methods 
Among	 cases	 and	 controls,	 summary	 statistics	 for	 alcohol	 intake	 and	 established	 risk	 factors	 of	
breast	 cancer	 were	 calculated	 for	 each	 center.	 Cases	 and	 controls	 were	 grouped	with	 respect	 to	
their	alcohol	 intake	 in	never	drinkers,	ex-drinkers	and	current	drinkers.	The	distribution	of	alcohol	
levels	 in	 control	 subjects	 was	 used	 to	 compute	 cutoff	 points	 and	 medians	 for	 tertiles	 of	 alcohol	
among	 current	 drinkers.	 For	 intra-center	 comparisons,	 tertiles	 were	 based	 on	 the	 control	
distribution	 for	 each	 center,	 while	 the	 combined	 sample	 was	 used	 for	 categorizations	 in	 overall	
analyses.	 The	 levels	 of	 breast	 cancer	 risk	 factors	 across	 tertiles	 of	 alcohol	 intake	 were	 evaluated	
among	controls	by	one-way	analysis	of	variance	and	χ2	tests	[33].	
For	risk	analysis,	multiple	 logistic	regression	was	used	to	estimate	the	association	of	alcohol	 intake	
with	 the	 risk	 of	 developing	breast	 cancer,	 adjusting	 for	 potential	 confounders.	 Relative	 risks	were	
estimated	 as	 odds	 ratios	 in	 alcohol	 intake	 categories	 compared	 to	 never	 drinkers.	 To	 assess	 the	
presence	of	a	linear	trend	of	risk	across	categories	of	alcohol	intake,	tests	for	trend	were	computed	
by	including	in	the	logistic	models	a	variable	with	the	median	value	for	the	corresponding	tertile	of	





Information	 on	 alcohol	 intake	 was	 available	 in	 315	 cases	 and	 364	 controls	 (94.2%	 of	 study	
participants).	As	expected,	cases	had	higher	body	mass	index,	age	at	first	childbirth,	family	history	of	
breast	cancer	and	history	of	benign	breast	disease,	but	only	age	at	first	childbirth	and	family	history	
of	 breast	 cancer	 reached	 statistical	 significance.	 Age	 at	 menarche,	 age	 at	 menopause	 and	 parity	
were	similar	among	cases	and	controls	(table	1).	
The	proportion	of	current	drinkers	and	ex-drinkers,	as	well	as	alcohol	intake	among	current	drinkers	
varied	markedly	 across	 centers.	 In	 the	 control	 group,	 Zeist	 had	 the	 highest	 proportion	 of	 current	
drinkers	 (78.7	%),	Málaga	had	 the	 lowest	 (5.9	%),	and	Coleraine	had	 the	highest	proportion	of	ex-
drinkers	 (33.7	%).	 There	were	only	3	ex-drinkers	 in	Málaga,	 all	of	 them	cases	 (table	2).	Berlin	and	
Zeist	 had	 the	 highest	 average	 alcohol	 intake	 among	 current	 drinkers	 (14.0	 and	 13.1	 g/day	
respectively),	while	Málaga	had	 the	 lowest	 (3.0	g/day).	 The	overall	mean	concentration	of	alcohol	
intake	in	controls	was	11.8	g/day	(table	3).	
The	 relation	 between	breast	 cancer	 risk	 factors	 and	 alcohol	 intake	was	 examined	 among	 controls	
(table	 4).	 Ex-drinkers	 had	 the	 highest	 age	 at	 first	 childbirth,	 frequency	 of	 use	 of	 estrogen	
replacement	 therapy	 and	 frequency	 of	 personal	 history	 of	 benign	 breast	 disease	 and	 the	 lowest	
body	mass	index	and	proportion	of	low	socioeconomic	status.	Never	drinkers	had	the	highest	body	
mass	index	and	proportion	of	parous	women,	and	the	lowest	proportion	of	smokers,	family	history	
of	 breast	 cancer	 	 and	 low	 socioeconomic	 status.	 As	 an	 indirect	 evidence	 of	 the	 validity	 of	 the	




Compared	 to	 never	 drinkers,	 the	 overall	 center-	 and	 age-adjusted	 relative	 risk	 (RR)	 for	 current	
drinkers	was	1.00	(95%	confidence	interval	[CI]:	0.70	to	1.43;	p	=	0.98)	(table	2).	The	RR	for	current	
drinkers	ranged	from	0.66	in	Zurich	to	2.76	in	Málaga,	but	the	confidence	intervals	for	the	individual	
centers	were	wide	 and	 overlapped	 one	 another.	 There	was	 also	 no	 evidence	 of	 effect	 of	 alcohol	
when	 current	 drinkers	 were	 analyzed	 by	 amount	 of	 alcohol	 intake.	 The	 overall	 center-	 and	 age-
adjusted	 RR	 estimates	 for	 current	 drinkers	 in	 the	 first,	 second	 and	 third	 tertile	 of	 alcohol	 intake	
compared	to	never	drinkers	were	1.00,	0.98	and	1.06,	respectively	(table	5).	The	overall	center-	and	
age-adjusted	 RR	 for	 ex-drinkers	 compared	 to	 never	 drinkers	 was	 1.66	 (95%	 CI:	 1.06	 to	 2.62;	 p	 =	




age	at	 first	 childbirth	did	not	materially	affect	 the	 results	 (table	5).	The	 risk	 factor-adjusted	RR	 for	
current	drinkers	 in	 the	 first,	 second	and	 third	 tertile	of	alcohol	 intake	compared	 to	never	drinkers	











this	 information.	Among	 current	drinkers,	 breast	 cancer	 risk	 estimates	were	higher	 for	 those	who	
began	drinking	before	age	40	compared	to	those	who	began	drinking	after	age	40	(RR	compared	to	










examined	 by	 reported	 use	 of	 estrogen	 replacement	 therapy,	 no	 systematic	 differences	 of	 effect	















Study,	 prospective	 data	 was	 used	 to	 evaluate	 selection	 and	 recall	 bias	 in	 case-control	 studies	 of	





collected,	adjustment	 for	energy	 intake	and	other	dietary	 factors	had	no	substantial	effect	on	 risk	
estimates	for	alcohol	[6,	9,	23,	35,	36,	39].	
Finally,	 the	 EURAMIC	 study	was	not	 designed	primarily	 to	 evaluate	 the	 association	of	 alcohol	 and	
breast	 cancer.	 Information	 on	 alcohol	 consumption	 was	 derived	 through	 locally	 developed	
questionnaires,	 reflecting	 the	different	patterns	of	 intake	 in	 the	different	 countries,	but	without	a	
formal	 validation	 procedure.	 Previous	 studies,	 however,	 suggest	 that	 even	 simple	 questionnaires	
provide	useful	estimates	of	regular	alcohol	intake	over	extended	periods	of	time	[12].	Furthermore,	
the	 strong	 correlation	 between	 reported	 alcohol	 intake	 and	 prevalence	 of	 smoking	 in	 our	 data	
reinforces	 the	 validity	 of	 our	 questionnaires	 to	 discriminate	 groups	 of	 participants	 with	 different	
consumption	habits.	
The	 epidemiologic	 evidence	 linking	 alcohol	 intake	 to	 breast	 cancer	 is	 persuasive,	 although	 some	
studies	 have	 shown	 little	 or	 no	 association	 [21,	 26,	 28].	With	 intakes	 of	 alcohol	 below	 30	 g/day,	
however,	the	estimated	effect	is	small	and	may	be	difficult	to	detect	[19,	35,	36].	 In	our	study,	the	
median	intake	of	alcohol	among	current	drinkers	was	6.0	g/day	and	the	median	of	the	highest	tertile	
of	 intake	was	20.0	g/day,	due	 in	part	 to	the	exclusion	of	patients	with	a	history	of	drug	or	alcohol	




of	past	heavy	drinkers.	Unfortunately,	 information	on	past	 level	of	 intake	among	ex-drinkers	 is	not	
available	in	our	dataset.	The	differences	in	risk	estimates	for	ex-drinkers	across	the	EURAMIC	centers	











of	 body	 mass	 index.	 This	 interaction	 was	 almost	 significant	 (p	 =	 0.08),	 but	 the	 variability	 of	 risk	
estimates	in	each	individual	category	of	drinking	status	by	body	mass	index	group	makes	it	difficult	
to	 interpret	 this	 finding.	 In	 our	 study,	 no	 interaction	 was	 evident	 between	 alcohol	 intake	 and	








small	 and	 did	 not	 reach	 statistical	 significance.	 Hiatt	 et	 al.	 [15]	 found	 higher	 risk	 among	 current	
drinkers	who	began	drinking	before	age	30,	but	not	among	ex-drinkers.	As	 in	our	 study,	 the	small	
number	of	past	drinkers	in	each	of	these	categories	makes	risk	estimates	less	reliable.	
Several	biological	mechanisms	have	been	suggested	to	explain	the	causal	role	of	the	alcohol	 in	the	
etiology	of	 breast	 cancer.	Hormone-related	mechanisms	 include	 stimulation	of	 prolactin	 secretion	
[40],	 altered	 production	 or	 metabolism	 of	 estrogens	 and	 androgens,	 and	 reduced	 melatonin	




[1],	 increased	 lipid	 peroxidation	 and	 reduction	 of	 antioxidant	 capacity	 ,	 and	 the	 presence	 of	




In	 conclusion,	 our	 results	 do	 not	 support	 a	 dose-response	 effect	 of	 alcohol	 on	 breast	 cancer	 risk,	
although	consumption	levels	were	too	low	to	exclude	increased	risk	with	high	regular	intake.	Further	
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